Protective effects of green tea against prostate cancer (Q36448671)

14 August 2017

1 reference

title

Protective effects of green tea against prostate cancer (English)

1 reference

14 August 2017

1 reference

4

Colin W Binns

1 reference

14 August 2017

Andy H Lee

1

1 reference

PubMed ID

16613539

14 August 2017

Michelle L Fraser

series ordinal

2

1 reference

PubMed ID

16613539

14 August 2017

Xingqiong Meng

series ordinal

3

1 reference

14 August 2017

1 April 2006

1 reference

Expert Review of Anticancer Therapy

14 August 2017

1 reference

14 August 2017

6

1 reference

14 August 2017

507-513

1 reference

14 August 2017

4

1 reference

Mass screening of prostate cancer in Changchun City of China.

14 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Protective effect of green tea on the risks of chronic gastritis and stomach cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Green tea and risk of breast cancer in Asian Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Impact of diet on prostate cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Protective effect of green tea against prostate cancer: A case‐control study in southeast China

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Green tea composition, consumption, and polyphenol chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Consumption of non-alcoholic beverages and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Smoking, alcohol, coffee, tea, caffeine, and theobromine: risk of prostate cancer in Utah (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Black tea consumption and cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Tea consumption and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Green tea catechins partially protect DNA from (.)OH radical-induced strand breaks and base damage through fast chemical repair of DNA radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Structure-activity relationships for inhibition of human 5alpha-reductases by polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Matrix metalloproteinase inhibition by green tea catechins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Gene expression profile in human prostate LNCaP cancer cells by (--) epigallocatechin-3-gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Tea consumption and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Chemoprevention of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

A case-control study of diet and prostate cancer in Japan: possible protective effect of traditional Japanese diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Alcohol and other beverage use and prostate cancer risk among Canadian men

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Tea and other beverage consumption and prostate cancer risk: a Canadian retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.4.507

21 January 2018

Identifiers

DOI

10.1586/14737140.6.4.507

1 reference

14 August 2017

1 reference

PubMed ID

16613539